Osteoinductive protein mixtures and purification processes
CA 2107481 C · Owner: Sulzer Orthopedics Biologics Inc. · Inventors: Poser, James W.; Benedict, James J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for purifying bone-derived osteoinductive factors including an ultrafiltration process, an anion exchange process, a cation exchange process, and a reverse phase HPLC process. The ultrafiltration process preferably includes a first ultrafiltration step using a membrane having a nominal molecular weight cutoff of approximately 100 kilodaltons (kD) and a second ultrafiltration step employing a membrane having a nominal molecular weight cutoff of approximately 10 kD. For the anion exchange process, a strongly cationic resin is used preferably having , quaternary amine functional groups. Typically the eluant, for the anion exchange process has a conductivity from about 10,260 …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 21, 1992 and granted December 3, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 21, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 21, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.